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ABSTRACT
Purpose: To describe the epidemiology of Microbial Keratitis (MK) in Uganda.
Methods: We prospectively recruited patients presenting with MK at two main eye units in
Southern Uganda between December 2016 and March 2018. We collected information on
clinical history and presentation, microbiology and 3-month outcomes. Poor vision was
defined as vision < 6/60).
Results: 313 individuals were enrolled. Median age was 47 years (range 18–96) and 174 (56%)
were male. Median presentation time was 17 days from onset (IQR 8–32). Trauma was reported by
29% and use of Traditional Eye Medicine by 60%. Majority presented with severe infections
(median infiltrate size 5.2 mm); 47% were blind in the affected eye (vision < 3/60). Microbiology
was available from 270 cases: 62% were fungal, 7% mixed (bacterial and fungal), 7% bacterial and
24% no organism detected. At 3 months, 30% of the participants were blind in the affected eye,
while 9% had lost their eye from the infection. Delayed presentation (overall p = .007) and prior
use of Traditional Eye Medicine (aOR 1.58 [95% CI 1.04–2.42], p = .033) were responsible for poor
presentation. Predictors of poor vision at 3 months were: baseline vision (aOR 2.98 [95%CI
2.12–4.19], p < .0001), infiltrate size (aOR 1.19 [95%CI 1.03–1.36], p < .020) and perforation at
presentation (aOR 9.93 [95% CI 3.70–26.6], p < .0001).
Conclusion: The most important outcome predictor was the state of the eye at presentation,
facilitated by prior use of Traditional Eye Medicine and delayed presentation. In order to improve
outcomes, we need effective early interventions.
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Background
Microbial keratitis (MK) can be caused by a range of
pathogens including, bacteria, viruses, protozoa, and
fungi. It is characterized by acute or sub-acute onset
of pain, conjunctival hyperemia, and corneal ulceration
with a stromal inflammatory cell infiltrate.1
MK has been described as a “silent epidemic”, which
leads to substantial morbidity, related to blindness, pain,
and stigma.2 It is the leading cause of unilateral blindness
after cataract in Tropical regions estimated at 2 million
cases of monocular blindness per year.3 In 2017,
1.3 million individuals were bilaterally blind from corneal
opacity globally (excluding trachoma and vitamin
A deficiency), accounting for 3.2% of the binocular
blindness.4 In Sub-Saharan Africa (SSA), MK is an impor-
tant cause of binocular blindness and is responsible for
about 15% of the monocular blindness (Nigeria National
Survey).5,6 The only report of the incidence in SSA is from
Malawi in 1994, which suggested a rate of around 180/
100,000/year.7 Rates in high-income settings are lower at
5–10/100,000.8–10
MK frequently leads to sight-loss from dense corneal
scarring, or even loss of the eye, especially when the
infection is severe and/or appropriate treatment is
delayed. A good outcome depends on early appropriate
treatment, supported by correct identification of the cau-
sative organism, and careful follow-up.11,12 In low and
middle-income countries (LMIC), these resources are not
readily available and outcomes tend to be poor.13
Literature on MK in SSA is extremely sparse, only
one audit from an LMIC setting (Tanzania) has pre-
viously reported outcomes of MK at discharge in
SSA.13 Here, in this large prospective cohort study
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from South-Western Uganda, we describe patient pre-
sentation, causative organisms, 3-month outcomes,
and investigate their determinants.
Methods
Ethical statement
This study followed the tenets of the Declaration of
Helsinki. It was approved by the London School of
Hygiene & Tropical Medicine Ethics Committee (Ref
10647), Mbarara University Research Ethics Committee
(Ref 10/04-16) and Uganda National Council for
Science and Technology (Ref HS-2303). Written
informed consent in the local language was obtained
before enrolment. If the patient was unable to read, the
information was read to them, and they were asked to
indicate their consent by application of their thumb-
print, which was independently witnessed.
Study design and setting
In this cohort, we prospectively enrolled patients with
MK that presented to Ruharo Eye Centre (REC) and
Mbarara University and Referral Hospital Eye Centre
(MURHEC) from December 2016 to March 2018.
MURHEC is a government-owned tertiary eye unit
established in 2013. It provides mostly free services and
sees about 6,000–10,000 patients/year. REC is a church-
run fee-paying tertiary eye hospital founded in the 1960s.
It sees about 20,000–25,000 patients/year. Both hospitals
are located in Mbarara Municipality, South-Western
Region, Uganda. In order to investigate the seasonal
variation in the presentation of MK, we aimed to recruit
all MK cases presenting during at least one year.13
Study participants
MK was defined as loss of corneal epithelium (of at least
1-mm diameter) with underlying stromal infiltrate,
associated with any or all signs of inflammation (conjunc-
tival hyperemia, anterior chamber inflammatory cells, ±
hypopyon).14 We also included patients presenting with
a deep corneal abscess (of at least 1 mm), defined as
having all the features of MK, but without an epithelial
defect. We excluded those not willing to participate, those
not willing to return for follow-up, pregnant women,
lactating mothers and those aged below 18 years.
Assessment
We documented basic demographic information and
their ophthalmic history. This included the circumstances
in which their eye became infected, predisposing factors,
treatment received, and their “health care journey” before
reaching the eye hospital. Presenting Log MAR
(Logarithm of Minimum Angle of Resolution) visual
acuity at 2 m in a dark room was measured using Peek
Acuity software.15 Participants were examined with a slit
lamp to assess the anterior segment using a structured
protocol, including eyelid assessment, corneal ulcer fea-
tures, anterior chamber (flare, cells, hypopyon shape, and
size) and perforation status. Infiltrate size was determined
from the greatest diameter of the infiltrate (major axis)
and the widest perpendicular diameter (minor axis).14
The final infiltrate size was then derived as the geometric
mean of these two diameters.14 The same was repeated
after fluorescein staining of the ulcer to determine epithe-
lial defect sizes. High-resolution digital photographs with
and without fluorescein staining were taken with a Nikon
SLR 7200 digital camera with Macro lens.
Corneal scrape specimens were collected from the
ulcer at a slit lamp or an operating microscope, using
21G needles after application of a proxymetacaine
(minims) anesthetic eye drops. Samples underwent
processing for the Gram stain, Potassium Hydroxide
[KOH] stain, Calcofluor White [CFW] stain and direct
inoculation on culture media (Sheep’s Blood Agar
[BA], Chocolate Agar [HBA], Potato Dextrose Agar
[PDA] and Brain Heart Infusion broth [BHI]). Two
sterile corneal swab samples were taken for pan fungal
gene sequencing. The number of corneal samples was
dependent on how much material could be safely
scraped from the cornea. The order was samples for
microscopy, agar, broth, and finally corneal swabs.
In addition, a random blood sugar test and HIV
counseling and testing were offered, as per the Uganda
Ministry of Health HIV testing protocol. For those who
were confirmed as HIV positive, a CD4 test was per-
formed to determine the level of immune suppression
and they were referred to the HIV care center, which is
on the hospital site.
Microscopy, culture, and antimicrobial sensitivity
work were done at the Mbarara University Department
of Microbiology. The technician underwent initial train-
ing in ocular microbiology at the Aravind Eye Hospital
System, department of ocular Microbiology in Madurai,
India and had a site supervision visit by amycologist from
the London School of Hygiene & Tropical Medicine.
Immediate CFW staining was also done in the side lab at
MURHEC on a fluorescein microscope (Zeiss Primostar
ILED) by the attending ophthalmologist. Agar plates and
broths were incubated and read daily at 35–37°C for
bacteria for up to 7 days and at 25°C for up to 21 days
for fungi. Organism identification and sensitivity testing
(MIC/zone of inhibition) were performed using standard
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microbiological techniques. We followed a previously
described approach for reporting positive microbiology
results.16 Briefly, bacteria were identified using routine
biochemical identification tests. Identification of fungi
was according to the macroscopic appearance of cultures
on potato dextrose andmicroscopic appearance of conidia
and spore-bearing structures. Positive culture was growth
at the site of inoculation or growth on one solid medium
consistent with microscopy; or semiconfluent growth at
the site of inoculation on one solid medium (if bacteria);
or growth of the same organism on repeated scraping. If,
by microscopy, hyphae were observed in corneal tissue,
but failed to grow in culture, the causative organism was
reported as fungal.
Treatment and follow-up
Patients were treated empirically at presentation and
the treatment choice was reviewed when the micro-
biology results became available. Patients with fungal
keratitis were treated with Natamycin 5% eyedrops
(Zonat Sunways India), those with bacterial
keratitis were treated with Ofloxacin 0.3% eyedrops
(Biomedica Remedies-India). Patients with fungal
infection were treated hourly day and night for the
first 3 days and then hourly while the patient was
awake for 2 weeks. This was changed to 2-hourly for
another 2 weeks and then tapered to 4 times a day
until healed. For bacterial infections, patients were
treated hourly day and night for the first 3 days and
then reduced to 6 times a day for a further week. All
patients with fungal MK were also given Ofloxacin
0.3% eye-drops four times a day as prophylaxis until
all epithelial defects were healed. In addition, those in
pain were treated with Atropine 1% eye-drops (locally
formulated) and oral Paracetamol tablets. Raised
intraocular pressure was treated with Timolol 0.5%
eye-drops (locally formulated). Those with presumed
viral keratitis were treated with Acyclovir 3% eye
ointment (CIPLA India) five times a day for 3
weeks. Most patients were admitted during the first
week.
After the initial assessment patients were seen
on day 2, day 7, day 21, and day 90 (3 months).
Additional assessments were conducted as clinically
indicated. The main outcome measures were final best-
corrected vision at 3 months, blindness (<3/60 in the
affected eye) at 3 months, and loss of the eye at 3
months. Scar density was also graded as “no scar”
(clear cornea), “mild scar” (anterior chamber structures
clearly visible through the scar), “moderate scar” (ante-
rior chamber structures vaguely visible through the
scar) and “dense scar” (anterior chamber structures
completely obscured by the scar).
Analysis
Data were analyzed in STATA v14. To describe the
presentation of MK, summary frequency tables of
demographics, presentation time, clinical history and
clinical features were generated. Presentation time was
classified as prompt (0–3 days), early (4–7 days), inter-
mediate (8–14 days), late (15–30 days) and very late
(more than 30 days).17 In addition, a summary tally of
patients that presented by month across one year
(2017) was generated to describe the presentation pat-
tern. This was compared to local rainfall, humidity and
temperature patterns. Local weather data were obtained
from the weather and climate repository.18 For presen-
tation purposes, Log MAR visual acuity measurements
were converted to the Snellen scale and categorized
according to the WHO classification system.19
We used two different analytical approaches. We first
took a causal modeling approach to explore the associa-
tion of six risk factors of interest with visual acuity at
presentation. These six factors were (Traditional Eye
Medicine) TEM use, history of trauma, delayed presenta-
tion, distance from hospital, distance from nearest health
center (HC), and organism type. In order to inform our
modeling choices, we first drew Direct Acyclic Graphs
(DAGs), using www.daggity.net v2.3 software, to identify
relevant variables to adjust for in the multivariable logistic
regression model.20 A DAG is a representation of the
hypothesized order of events from the exposure to the
outcome. It allows the researcher to logically map out
relationships between different variables and identify
those to adjust for to determine the overall effect of the
exposure on the outcome. A change in point estimate
criteria was used to assess for confounding and multi-
collinearity. Each main exposure was separately adjusted
for confounding factors and final adjusted odds ratios
(aOR) recorded.
The second modeling approach was to build
a predictive model for visual acuity outcomes at 3
months, using baseline clinical features. Patients with-
out 3-month data were excluded from the analysis.
Ordinal logistic regression analysis of the WHO
Snellen visual acuity categories was used to identify
factors associated with visual acuity at 3 months.
Univariable regression was performed to generate
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crude odds ratios (cOR). Variables with a p-value less
than 0.1 were initially included in the multivariable
model. A backward stepwise approach was then used
until only the variables with a p-value of less than 0.05
were retained. Adjusted ORs were reported for the final
model.
Results
Participants
Patient enrolment is illustrated in Figure 1. The baseline
characteristics of the patients are shown in Table 1.
Median age was 47 years (IQR 35–60, total range 18–96
years), and the majority (56%) were male. Over a quarter
had never had any formal education. Most (70%) were
married and most (70%) were the heads of households.
Median distance from home to the eye hospital was 79 km
(IQR 52–128, total range 0.2–378 km). Median distance
from home to their nearest HC was 3 km (IQR 1–4, total
range 0–45 km). The main occupation was farming
(70%). The baseline characteristics of the patients who
were lost to follow-up and those who completed 3months
were similar (Supplementary Table 1).
Presentation pattern
Figure 2 illustrates the number presenting per month
throughout 2017, compared to rainfall, temperature and
humidity patterns. Patients presented throughout the year,
with peaks inMay to July andOctober toNovember, which
corresponded with the harvest seasons. April and
November had the greatest rainfall. Temperature and
humidity were constant throughout the year.
Figure 1. Flow diagram of participants who were enrolled in the cohort study.
Table 1. Demographic characteristics of the study participants.
Variable n/313 (%)
Age (median = 47, IQR 35–60) in years
< 30 years 54 (17%)
30–40 years 63 (20%)
40–50 years 59 (19%)
50–60 years 66 (21%)
> 60 years 71 (23%)
Gender
Female 139 (44%)
Male 174 (56%)
Occupation
Farmer 220 (70%)
Non-farmer 93 (30%)
Education
None 84 (27%)
Primary level 162 (52%)
Secondary level 45 (14%)
Tertiary level 22 (7%)
Marital status
Unmarrieda 95 (30%)
Married 218 (70%)
Economic statusb
Lower 85 (28%)
Middle 189 (63%)
Upper 26 (9%)
Being head of household
Yes 212 (68%)
No 101 (32%)
Distance from the eye hospital (median = 79 km
IQR 52–128)
0–50 km 77 (25%)
50–100 km 111 (35%)
100–150 km 75 (24%)
>150 km 50 (16%)
Nearest health center (Median 3 km, IQR
1–4 km)c
Clinic 10 (3%)
HC II 103 (33%)
HC III 96 (31%)
HC IV 43 (14%)
Hospital 32 (10%)
Don’t know 29 (9%)
aUnmarried included single divorced and widowed.
bEconomic status was self-reported where participants compared them-
selves with their neighborhood as “poor”, “neither poor nor rich” or
“rich”, n was 300 with 13 non-reported values.
cThe nearest health center was the health center that the patients con-
sidered nearest to them regardless of the level of that health center
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Presenting history
The median time from onset of symptoms to presenta-
tion time at the eye unit was 17 days (IQR 8–32, total
range 0–370 days), Table 2. Only 7% of the participants
presented “promptly” (within 3 days). Only 29% of the
participants reported a history of trauma, and most
(74%) of these were classified as organic in nature.
Many patients (60%) reported use of TEM.
Clinical features and microbiology
Table 3 shows the clinical features at presentation,
including detailed characteristics of the ulcers and
microbiology results. Specimen for microbiology was
collected in 270 patients. Due to limited amounts of
sample material, it was not possible to perform all tests
on all those sampled. Almost half of the participants
(47%) had a visual acuity of less than 3/60 (blind) in the
affected eye at presentation. Microbiology results were
available in 270/313 (86.3%) participants. Corneal
scrapping was not performed on 43 participants who
either did not consent, had deep-seated infiltrates, or
small infiltrates (less than 0.5 mm). Overall, most infec-
tions were fungal (62%), 7% were bacterial and 7% were
mixed (fungal and bacterial). Fifty-seven (20%) of the
corneal scrapping samples were negative on both
microscopy and culture.
Outcomes
Table 4 shows the outcomes of the 260 participants seen
at the 3-month follow-up. At 3 months, the visual acuity
was better than baseline vision. Median final visual acuity
(Log MAR) was 0.4 (IQR 0–1.5) compared to a baseline
Figure 2. Presentation of patients with MK, by month in 2017 (n = 261). Monthly average minimum and maximum
temperatures, average humidity and the number of days with rain are overlaid. Humidity was in percentage but was scaled
to tens (divided by 10) to fit on the plot scale.
Table 2. Clinical history.
Variable n/313 (%)
Presenting time (median = 17 days, IQR 8–32)a
Prompt 0–3 days 23 (7%)
Early 4–7 days 46 (15%)
Intermediate 8–14 days 72 (23%)
Late 15–30 days 79 (26%)
Very late >30 days 90 (29%)
Most important symptom (self-reported)
Pain 144 (46%)
Reduced vision 137 (44%)
Other 32 (10%)
History of trauma
Yes 91 (29%)
No 220 (71%)
Used traditional eye medicine
Yes 188 (60%)
No 125 (40%)
Used other treatmentb
Yes 275 (88%)
No 38 (12%)
Diabetic (n = 280)c 22 (8%)
HIV positive (n = 284)c 37 (13%)
an was 310. For 3 patients the date of onset could not be well ascertained.
Some patients had used other forms of eye drops prior to presentation and
there was some overlap among those who used TEM and other eye drops.
bIt was not possible to ascertain the forms of other treatment used.
cSome patients declined to be tested for HIV and diabetes
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median of 1.3 (IQR 0.3–2.5). Visual acuity at 3 months
improved in 139 participants, worsened in 66 partici-
pants and remained unchanged in 56 (sign rank test
p < .0001). Visual acuity was categorized according to
the WHO classification system and poor outcome was
considered as vision < 6/60.19 Thirty percent of the
participants were blind in the affected eye (vision less
than 3/60) and 9% had lost their eye to infection due to
evisceration following endophthalmitis.
Causal modeling for poor presentation
Figure 3 shows the overall model for several variables of
interest that we considered in the causal analysis for poor
presenting vision. The results are summarized in Table 5
and their corresponding outputs from the DAGitty soft-
ware in Supplementary Figures 1–5. Those who reported
TEM were estimated to have overall 1.6 times the odds of
being in a poorer vision category compared to those who
did not use TEM (aOR 1.62 [95%CI 1.04–2.54], p = .033).
It was considered plausible that some of this effect was
mediated through delayed presentation and/or organism
type, and after adjusting for these factors as well, the aOR
was 1.47 [95%CI 0.91–2.38], p = .11. There was some
evidence (p = .033) of an association between the cate-
gory of presentation time and presenting vision, with the
lowest odds of poorer vision being in those that present
earliest and increasing odds as delay increases. No evi-
dence (p = .609) was found of an association between
trauma and presenting visual acuity, but strong evidence
was found of an association between presenting visual
acuity and both distance from the eye hospital (p < .001)
and distance from the nearest HC (p = .007).
Table 3. Clinical features and diagnosis at presentation (n = 313).
Variable Median
(IQR [Total
Range])
Infiltrate size (mm)a 5.2 (3.3–7.7 [0.5–13])
Epithelial defect size (mm)a 3.9 (2.4–6.5 [0–14])
Variable n/313 (%)
Snellen Visual Acuity in affected eye
(n = 312)
6/5–6/18 102 (33%)
6/24–6/60 42 (12%)
5/60–3/60 24 (8%)
2/60–1/60 33 (11%)
Counting fingers-light perception 103 (33%)
No light perception 9 (3%)
Snellen visual acuity in non-affected
eye (n = 312)
6/5–6/18 278 (89%)
6/24–6/60 16 (5%)
5/60–3/60 2 (1%)
2/60–1/60 4 (1.2%)
Counting fingers-light perception 6 (2%)
No light perception 6 (1.8%)
Slough (n = 312)b
No slough 62 (20%)
Flat 124 (40%)
Raised 126 (40%)
Infiltrate edge (n = 293)
Defined 35 (12%)
Serrated 258 (82%)
Not visible 20 (6%)
Satellite lesions present (n = 304)
Yes 178 (57%)
No 126 (40%)
Infiltrate colour (n = 288)
White 148 (47%)
Cream 106 (34%)
Other colour 34 (11%)
Hypopyon (median height 1.3mm IQR
0.9–2.9, n = 301)
Yes 94 (30%)
No 217 (69%)
Site of ulcer (n = 310)c
Peripheral 27 (9%)
Paracentral 64 (21%)
Central 219 (70%)
Perforation status
Not perforated 237 (76%)
Impending 31 (10%)
Perforated 48 (12%)
Perforated & sealed 7 (2%)
Overall Laboratory diagnosis (n = 270)d
Unknown 65 (21%)
Bacterial 20 (6%)
Fungal 168 (54%)
Mixed (bacteria/fungal) 17 (5%)
Where n < 313 was due to some missing data: percentages calculated for
313 and rounded off to the nearest whole number.
aThese were calculated as the geometrical means using the MUTT protocol.
The upper limits exceeded normal corneal diameter for some lesions,
which extended up to the sclera.
bRaised slough was when the corneal infiltrate profile was raised, flat
slough was when the profile was flat while no slough is when there
was no debris noted.
cSite of ulcer was peripheral when the ulcer was marginal, paracentral was
when the ulcer was not marginal but not within 4 mm of the center of
the cornea, central was when the ulcer was within the central 4 mm of
the cornea.
Impending perforation is when the clinicians felt the ulcer would perforate
in the next 48 h.
dSpecimen for microbiology was collected in 270 patients. Due to limited
amounts of sample material, it was not possible to perform all tests on all
those sampled. The order of material collection was 3 slide smears (gram,
KOH, CFW), 3 agar inoculations (blood, chocolate, PDA) and 1 broth (BHI)
depending on available material.
Table 4. Outcomes at 3 months.
Variable n/260 (%)
Visual acuity in the affected eye (Snellen)
6/5–6/18 138 (53%)
6/24–6/60 37 (14%)
5/60–3/60 7 (3%)
2/60–1/60 14 (5%)
Counting fingers-light perception 31 (12%)
No light perception 33 (13%)
Visual acuity in the non-affected eye
6/5–6/18 229 (90%)
6/24–6/60 11 (4%)
5/60–3/60 2 (1%)
2/60–1/60 0 (0%)
Counting fingers-light perception 6 (2%)
No light perception 7 (3%)
Outcome
Healed no scar 34 (12%)
Healed mild scar 83 (30%)
Healed moderate scar 65 (24%)
Healed dense scar 46 (17%)
Eviscerated 24 (9%)
Not healed 20 (7%)
Staphyloma 4 (1%)
126 S. ARUNGA ET AL.
Interestingly, even after adjusting for delayed presenta-
tion there remained strong evidence of an association
(p < .0001 and p = .009).
Predictors of outcome
In the final multivariable model, worse visual acuity
outcome at 3 months was associated with baseline
vision, size of the infiltrate and perforation status at
presentation Table 6.
Discussion
This study describes the clinical history, signs, micro-
biological etiology, causes, and outcomes of MK in
Uganda. Most patients presented with poor vision. At
3 months, 30% had monocular blindness in the affected
eye and 1 in 10 lost their eye to infection.
Delayed presentation was common. Very few (7%)
presented within 3 days of symptom onset and this had
a direct impact on outcomes, as previously reported.13
In this study, delayed presentation after adjusting for
being a farmer, distance, economic status, education
status, trauma, TEM and previous use of other treat-
ment was associated with poor presenting vision.
Earlier studies indicate that prompt prophylactic anti-
biotic can prevent simple corneal abrasions developing
into MK, leading to much better outcomes.17,21,22 Most
late presenters had advanced ulcers, where treatment
could do little. We know from prior literature that once
an ulcer is advanced, treatment does relatively little to
change its course.23 From previous studies, it is recom-
mended that treatment of MK should be started as early
as possible to achieve optimal outcomes.17
Another important cause of poor vision at presenta-
tion was Traditional Eye Medicine use. In this study, 60%
of the patients reported TEM use. TEM increased the
Figure 3. A DAG framework showing the causal pathways for poor presenting vision. This diagram is adjusted to illustrate the role of
TEM. The solid lines indicate hypothesized direct relationships and the dashed lines indicate hypothesized indirect relationships.
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odds of poor presentation by 60% after adjusting for age,
sex, being a farmer, economic status, education level, and
distance. In our model, some of the effects of TEM
seemed to be mediated through delay and organism
type. But after adjusting for these, there was still an
estimated 40% increase in odds of poor presentation,
Table 5. Causal modeling for poor presenting vision (n = 313).
Variable
Univariable Analysis Multivariable Analysis
Multivariable analysis for
direct effect
Crude
ORa (95% CI) p-value
Adj.
OR (95% CI) p-value OR (95% CI) p-value
Model 1: Used Traditional Eye Medicine (TEM) as the main exposure of interestb
Used traditional eye medicine (TEM) 1.78 (1.17–2.70) 0.007 1.62 (1.04–2.54) 0.033 1.47 0.91–2.38 0.11
Model 2: Delayed presentation as the main exposure of interestc
Prompt 0–3 days 1 0.0004 1 0.033
Early 4–7 days 2.78 (1.07–7.20) 1.94 (0.70–5.39)
Intermediate 8–14 days 4.45 (1.84–10.7) 3.02 (1.17–7.79)
Late 15–30 days 5.58 (2.33–13.3) 3.57 (1.40–9.07)
Very late > 30 days 2.63 (1.11–6.25) 1.87 (0.74–4.72)
Model 3: Trauma as the main exposure of interestd
Positive history of trauma 0.94 (0.60–1.48) 0.810 1.13 (0.70–1.83) 0.609
Model 4: Distance from the eye hospital in km as the main exposure of intereste
0–50 km 1 < 0.0001 1 < 0.0001 1 < 0.0001
50–100 km 1.27 (0.73–2.21) 1.27 (0.73–2.21) 1.26 (0.71–2.21)
100–150 km 2.90 (1.60–5.23) 2.90 (1.60–5.23) 2.63 (1.45–4.80)
> 150 km 5.60 (2.87–10.9) 5.60 (2.87–10.9) 5.06 (2.58–9.92)
Model 5: Distance from nearest health center (for every km increase)e
Distance from nearest health center (for every km
increase)
1.22 (1.05–1.41) 0.007 1.22 (1.05–1.41) 0.007 1.21 (1.05–1.41) 0.09
Model 6: Type of organismf
No organism detected 1 0.105 1 0.101
Bacteria 1.25 (0.50–3.15) 1.43 (0.55–3.66)
Fungal 1.80 (1.05–3.07) 1.82 (1.06–3.13)
Mixed 2.49 (0.93–6.62) 2.71 (1.07–2.79)
aAll crude estimates were adjusted for age and sex. bUse of TEM was adjusted for age, sex, being a farmer, economic status, education level, distance from the
eye hospital, and distance from the nearest health center (n = 298). After adjusting for delay and organism type, the effect of TEM was OR 1.47 95% CI
0.91–2.38, p = 0.11. cDelayed presentation was adjusted for age, sex, being a farmer, distance, economic status, education level, TEM, trauma, and previous
use of prior treatment before presentation (n = 295). dHistory of trauma was a priori based on literature from previous studies. It was adjusted for age, sex,
being a farmer, TEM, distance, and prior treatment (n = 306). eLong distance from the eye hospital and long distance from the nearest health center were
only adjusted for age and sex (n = 309). Their crude and adjusted point estimates are the same. However, the direct effect of distance to eye hospital and
distance to nearest health center after adjusting for delay was still highly significant, p < 0.0001 and = 0.009. fType of organism was a forced priori and was
adjusted for trauma and use of TEM (n = 267).
Table 6. Factors at presentation predictive of a poor final visual acuity (WHO snellen ordinal scale) at 3 months (n = 260).
Variable
Univariate Analysis Multivariable Analysis
Crude ORa (95% CI) p-value Adjusted ORb (95% CI) p-value
Baseline visual acuity (for every line decrease in vision) 4.78 (3.59–6.35) < 0.0001 2.98 (2.12–4.19) < 0.0001
Presence of slough
None 1 0.007
Flat 1.91 (0.95–3.83)
Raised 2.95 (1.46–5.95)
Infiltrate edge being serrated 0.84 (0.58–1.24) 0.393
Satellite lesions being present 0.64 (0.40–1.03) 0.068 0.51 (0.28–0.90) 0.021
Infiltrate color
White 1 < 0.0001
Cream 2.70 (1.56–4.63)
Colored 6.37 (3.10–13.2)
Hypopyon present 2.16 (1.38–3.55) 0.002
Infiltrate size (for every 1 mm increase) 1.60 (1.44–1.79) < 0.0001 1.19 (1.03–1.36) 0.020
Perforation status at presentation
Not perforated 1 < 0.0001 1 < 0.0001
Impending perforation 11.9 (5.27–26.9) 2.86 (1.11–7.37)
Perforated and sealed 5.60 (1.44–21.8) 1.57 (0.31–7.76)
Perforated 41.0 (17.3–97) 9.93 (3.70–26.6)
HIV status being positive 0.85 (0.39–1.85) 0.683
Diabetes status being positive 0.81 (0.34–1.92) 0.630
Microbiology
No organism detected 1 0.063
Bacteria 1.48 (0.53–4.14)
Fungal 2.25 (1.19–4.26)
Mixed 2.80 (0.86–9.01)
aAll crude estimates were adjusted for age and sex. bFinal predictive model adjusted for age and sex.
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although the evidence for this associationwas weak.Many
people probably try TEM before attending hospital, as it
can be easily obtained within or close to home. In
Uganda, TEM is usually made from plant products. This
is concerning, as such substances may be toxic or harbor
infectious agents, such as fungal spores.7,24 Importantly,
our patients were open in admitting use of TEM, a widely
acceptable practice for treating MK.
Distance was an important cause of poor presenting
vision. This included distance to the eye hospital and
distance to the nearest HC. This highlighted a major
underlying problem of access to health services: the
further the HC, the lower the chances of promptly
starting appropriate treatment. In our model, even
after adjusting for delay, distance was still highly asso-
ciated with poor presenting vision meaning that there
were still other unexplained factors in this relationship.
As reported previously, severity of infection at pre-
sentation (vision, perforation status, and infiltrate size)
was the strongest predictor of outcome.23,25,26 Poor
vision at presentation (WHO Snellen categories) was
strongly associated with a worse visual outcome. Vision
is an easily measurable and reliable prognostic measure
that can support lower and mid-level cadres to make
the right clinical decisions. A perforated eye at presen-
tation had 10 times greater odds while an eye with an
impending perforation had 3 times greater odds of
a worse visual outcome compared to a non-perforated
eye. This was not surprising because keratoplasty ser-
vices are currently not available in Uganda. People who
presented with threatened or full perforation under-
went conjunctival flap or evisceration surgery depend-
ing on the extent of the perforation.
Most of our patients presented with large infiltrate
and epithelial defect sizes. Such median sizes would be
considered severe ulcers in a high-income setting. The
epithelial defect size was not included in the analysis
because it was highly correlated to the infiltrate size.
A large infiltrate size was associated with increased
odds of a worse final visual outcome.25,26
Most of the affected patients were aged between 31
and 60 years, which are the prime years for economic
productivity.13 About 70% of the affected people were
heads of households and sole breadwinners in their
home. Prolonged morbidity due to MK meant that
they could not provide for their dependents. In an
ongoing study, we have been exploring how MK affects
the quality of life and household incomes (unpublished).
The prevalence of HIV among our cohort was almost
double the national prevalence and diabetes was 4 times
the reported prevalence.27,28 A high prevalence of HIV
has been previously reported in people with MK.13,29
HIV and diabetes predispose to MK through immune
suppression: we conducted a nested case-control to test
for risk factors of MK including HIV and diabetes which
have been reported separately.
Understanding the seasonal pattern of presentation
is important to prepare a surveillance mechanism and
for hospitals to have expectant management. We found
that the presentation of MK tended to follow rainfall
patterns linked to agricultural activity. This was not
surprising since the majority (70%) of patients were
farmers. There was little variation in humidity and
temperature throughout the year. This region of
Uganda has two planting and harvesting seasons, one
in each half of the year following rains. Harvesting time
is May–July and November–January. These were the
periods when we recorded increased numbers of pre-
sentations. Farming (especially harvesting) has been
linked to ocular trauma which predisposes to MK.30
These corresponded with peak presentation to hospital.
April has modest farming activity, as people are waiting
for the harvesting season and it usually corresponds to
Easter holiday. August usually has almost no farming
activity since it comes at the end of the harvesting
season before the rains come again in September.
December had fewer patients presenting, possibly due
to the Christmas season.
It remains unclear if this seasonal variation was related
to trauma, as there were no clear seasonal differences in
the pattern of presentation among patients who reported
trauma and those who did not. We were surprised that
relatively few patients (29%) reported trauma, although
this is consistent with other studies from sub-Saharan
Africa (SSA). In an older study from Ghana, 39% of the
MK cases reported some form of eye injury prior to
onset.31 In two separate studies from Tanzania, 24% and
39% of the cases were associated with trauma.13,32 These
levels are somewhat lower than those from South Asia,
where around 75% are associated with an injury.31,33–36
The reason for this difference is not apparent.
Ocular microbiology is not performed in many set-
tings in SSA. As part of this study, we undertook to
build the capacity of the hospital to provide this service.
The overall microbiology yield was 80%. This was
a composite of all the microscopy and culture results.
Overall culture positive results were 55% similar to the
expected yield reported in literature.16,31
Strengths/limitations
This is the first large prospective cohort study in SSA to
describe outcomes of MK. Most of the reports have
described etiology and presentation.16,29,31,32 Only one
audit had attempted to describe outcomes.13 The large
number of patients gave sufficient power to analyze
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several factors associated with the main outcome mea-
sures. It was not possible to follow-up all the patients,
with around 20% not having 3-month outcome data;
however, no systematic differences were found between
those with and without final follow-up data.
Conclusion
This study provides an understanding of MK epide-
miology in Uganda. Majority of patients presented
late after having traveled large distances to seek spe-
cialist care. Most patients presented with severe
ulcers. The outcomes for many were poor, although
around half had some improvement of vision with
treatment. Predictive factors for these poor outcomes
were the state of the eye at presentation. There is
need to work on early interventions to prevent
patients reaching such a stage where little can be
done.
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